NPTH Fundamental Analysis - NEUPATH HEALTH INC

Fundamental Rating

NPTH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 15 industry peers in the Health Care Providers & Services industry. NPTH scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NPTH is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year NPTH has reported negative net income.

In the past year NPTH had a positive cash flow from operations.

In the past 5 years NPTH always reported negative net income.

Of the past 5 years NPTH 4 years had a positive operating cash flow.

1.2 Ratios

NPTH has a Return On Assets of -1.83%. This is comparable to the rest of the industry: NPTH outperforms 46.67% of its industry peers.

With a Return On Equity value of -3.75%, NPTH perfoms like the industry average, outperforming 53.33% of the companies in the same industry.

NPTH's Return On Invested Capital of 4.40% is fine compared to the rest of the industry. NPTH outperforms 80.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-1.83%
ROE	-3.75%
ROIC	4.4%

ROA(3y)-3.74%

ROA(5y)-5.69%

ROE(3y)-7.64%

ROE(5y)-10.74%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

NPTH has a Operating Margin (2.49%) which is in line with its industry peers.

NPTH has a Gross Margin of 19.09%. This is in the lower half of the industry: NPTH underperforms 66.67% of its industry peers.

NPTH's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	2.49%
PM (TTM)	N/A
GM	19.09%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.42%

GM growth 5Y-1.04%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NPTH is destroying value.

NPTH has about the same amout of shares outstanding than it did 1 year ago.

NPTH has more shares outstanding than it did 5 years ago.

The debt/assets ratio for NPTH has been reduced compared to a year ago.

2.2 Solvency

NPTH has an Altman-Z score of 1.72. This is a bad value and indicates that NPTH is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of NPTH (1.72) is better than 66.67% of its industry peers.

NPTH has a debt to FCF ratio of 6.29. This is a slightly negative value and a sign of low solvency as NPTH would need 6.29 years to pay back of all of its debts.

NPTH's Debt to FCF ratio of 6.29 is fine compared to the rest of the industry. NPTH outperforms 73.33% of its industry peers.

NPTH has a Debt/Equity ratio of 0.50. This is a neutral value indicating NPTH is somewhat dependend on debt financing.

NPTH has a Debt to Equity ratio of 0.50. This is in the better half of the industry: NPTH outperforms 80.00% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.5
Debt/FCF	6.29
Altman-Z	1.72

ROIC/WACC0.65

WACC6.8%

2.3 Liquidity

NPTH has a Current Ratio of 1.20. This is a normal value and indicates that NPTH is financially healthy and should not expect problems in meeting its short term obligations.

NPTH has a Current ratio of 1.20. This is amongst the best in the industry. NPTH outperforms 86.67% of its industry peers.

NPTH has a Quick Ratio of 1.20. This is a normal value and indicates that NPTH is financially healthy and should not expect problems in meeting its short term obligations.

NPTH has a Quick ratio of 1.20. This is amongst the best in the industry. NPTH outperforms 86.67% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.2
Quick Ratio	1.2

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for NPTH have decreased strongly by -928.57% in the last year.

The Revenue has grown by 14.65% in the past year. This is quite good.

NPTH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.96% yearly.

EPS 1Y (TTM)-928.57%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-15.38%

Revenue 1Y (TTM)14.65%

Revenue growth 3Y6.16%

Revenue growth 5Y7.96%

Sales Q2Q%25.16%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y100%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year14.59%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NPTH. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NPTH is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.

NPTH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NPTH is cheaper than 86.67% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	10.09
EV/EBITDA	6.54

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

NPTH does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NEUPATH HEALTH INC

TSX-V:NPTH (10/2/2025, 7:00:00 PM)

0.35

+0.02 (+6.06%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)08-14 2025-08-14/bmo

Earnings (Next)11-12 2025-11-12

Inst Owners24.93%

Inst Owner ChangeN/A

Ins Owners2.02%

Ins Owner ChangeN/A

Market Cap19.72M

Analysts80

Price Target0.51 (45.71%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-100%

EPS NY rev (3m)N/A

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)6.03%

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.25
P/FCF	10.09
P/OCF	7.57
P/B	0.92
P/tB	290.04
EV/EBITDA	6.54

EPS(TTM)-0.01

EYN/A

EPS(NY)0

Fwd EYN/A

FCF(TTM)0.03

FCFY9.91%

OCF(TTM)0.05

OCFY13.2%

SpS1.41

BVpS0.38

TBVpS0

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.83%
ROE	-3.75%
ROCE	6.11%
ROIC	4.4%
ROICexc	5%
ROICexgc	19.84%
OM	2.49%
PM (TTM)	N/A
GM	19.09%
FCFM	2.46%

ROA(3y)-3.74%

ROA(5y)-5.69%

ROE(3y)-7.64%

ROE(5y)-10.74%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.42%

GM growth 5Y-1.04%

F-Score5

Asset Turnover1.81

Health

		Industry Rank	Sector Rank
Debt/Equity	0.5
Debt/FCF	6.29
Debt/EBITDA	2.49
Cap/Depr	27.81%
Cap/Sales	0.82%
Interest Coverage	6.88
Cash Conversion	60.43%
Profit Quality	N/A
Current Ratio	1.2
Quick Ratio	1.2
Altman-Z	1.72

F-Score5

WACC6.8%

ROIC/WACC0.65

Cap/Depr(3y)39.19%

Cap/Depr(5y)26.48%

Cap/Sales(3y)1.5%

Cap/Sales(5y)1.05%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-928.57%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-15.38%

EPS Next Y100%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)14.65%

Revenue growth 3Y6.16%

Revenue growth 5Y7.96%

Sales Q2Q%25.16%

Revenue Next Year14.59%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y97.7%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year287.08%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-7.08%

FCF growth 3Y3.23%

FCF growth 5YN/A

OCF growth 1Y0%

OCF growth 3Y10.75%

OCF growth 5YN/A

NEUPATH HEALTH INC (NPTH.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens